REFERENCES
- Wainwright M, Grice NJ, Pye LEC. Phenothiazine Photosensitizers. Part 2. 3,7-Bis(arylamino)phenothiazines. Dyes Pigments 1999; 42: 45–51.
- Ho RCS. Medical management of stage IV malignant melanoma. Cancer 1995; 75: 735–741.
- Krementz ET, Carter RD, Sutherland CM, Muchmore JH, Ryan RF, Creech O. Regional chemotherapy for melanoma: a 35-year experience. Ann Surg 1994; 220: 520–535.
- Rivers JK. Melanoma. Lancet 1996; 347: 803–806.
- Roberts DJH, Cairnduff F. Photodynamic therapy of primary skin cancer: a review. Br J Plastic Surg 1995; 48: 360–370.
- Herd RM, Dover JS, Arndt KA. Basic laser principles. Dermatol Clin 1997; 15: 355–374.
- Corsaro C, Scalia M, Blanco AR, Aiello I, Sichel G. Melanins in physiological conditions protect against lipoperox-idation. A study on albino and pigmented Xenopus. Pigment Cell Res 1995; 8: 279–282.
- Rozanowska M, Ciszewska J, Korytowski W, Sarna T. Rose Bengal-photosensitized formation of hydrogen peroxide and hydroxyl radicals. J Photochem Photobiol B Biol 1995; 29: 71–77.
- Hadjur C, Richard MJ, Parat MO, Jardon P, Favier A. Photodynamic effects of hypericin on lipid peroxidation and antioxidant status in melanoma cells. Photochem Photobiol 1996; 64: 375–381.
- Busetti A, Soncin M, Jon G, Rodgers MM. High efficiency of benzoporphyrin derivative in the photodynamic therapy of pigmented malignant melanoma. Br J Cancer 1999; 79: 821–824.
- Soncin M, Busetti A, Biolo R, et al. Photoinactivation of amelanotic and melanotic cells sensitized by axially substituted Sinaphthalocyanines. J Photochem Photobiol B Biol 1998; 42: 202–210.
- Wainwright M. Non-porphyrin photosensitizers in bio-medicine. Chem Soc Rev 25 (1996) 351–359.
- Creagh TA, Gleeson M, Travis D, Grainger R, McDermott TED, Butler MR. Is there a role for in vivo methylene blue staining in the prediction of bladder tumour recurrence? Br J Urol 1995; 75: 477–479.
- Tuite EM, Kelly JM. Photochemical reactions of methylene blue and analogues with DNA and other biological substrates. J Photochem Photobiol B Biol 1993; 21: 103–124.
- Williams JL, Stamp J, Devonshire R, Fowler GJS. Methylene Blue and the photodynamic therapy of superficial bladder cancer. J Photochem Photobiol B Biol 1989; 4: 229–232.
- pith K, Ruck A, Stanescu A, Seger HG. Intraluminal treatment of inoperable oesophageal tumours by intraluminal photodynamic therapy with Methylene Blue. Lancet 1995; 345: 519–520.
- Potts AM. Further studies concerning the accumulation of polycyclic compounds on uveal melanin. Invest Ophthalmol 1964; 3: 399–405.
- Knorle R, Schnitz E, Feuerstein TJ. Drug accumulation in melanin: an affinity chromatographic study. J Chromatog B 1998; 714: 171–179.
- Link EM, Blower PJ, Costa DC et al. Early detection of melanoma metastases with radioiodinated methylene blue. Eur J Nucl Med 1998; 25: 1322–1329.
- Wainwright M, Phoenix DA, Rice L, Burrow SM, Waring J. Increased cytotoxicity and phototoxicity in the methylene blue series via chromophore methylation. J Photochem Photobiol B Biol 1997; 40: 233–239.
- Wainwright M, Phoenix DA, Laycock SL, Wareing DRA, Wright PA, Photobactericidal activity of phenothiazini-um dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol Lett 1998; 160: 177–81.
- Yu DS, Chang SY, Ma CP. Photoinactivation of bladder tumor cells by methylene blue: study of a variety of tumor and normal cells. J Urol 1990; 144: 164–168.
- Yu DS, Chang SY, Ma CP. Ultrastructural changes of bladder cancer cells following methylene blue-sensitized photodynamic treatment. Eur J Urol 1991; 19: 322–327.
- Yu DS, Chang SY, Ma CP. The effect of methylene blue-sensitized photodynamic treatment on bladder cancer cells: a further study on flow cytometric basis. J Urol 1993; 149: 1198–1204.
- Stockert JC, Juarranz A, Villanueva A, Catiete M. Photodynamic damage to HeLa cell microtubules induced by thiazine dyes. Cancer Chemother Pharmacol 1996; 39: 167–169.
- Rashid F, Horobin RW. Interactions of molecular probes with living cells and tissues. 2. A structure-activity analysis of mitochondrial staining by cationic probes, and a discussion of the synergistic nature of image-based and bio-chemical approaches. Histochemistry 1990; 94: 303–308.
- Pooler J, Valenzeno DP. Physicochemical determinants of the sensitizing effectiveness for photooxidation of nerve membranes by fluorescein derivatives. Photochem Photobiol 1979; 30: 491–498.
- Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colourimetric assay: assessment of chemosensitivity testing. Cancer Res 1987; 47: 936–942.
- Lin CW, Shulok JR, Kirley SD, Cincotta L, Foley JW. Lysosomal localization and mechanism of uptake of Nile blue photosensitizers in tumor cells. Cancer Res 1991; 51: 2710–2719.
- Link EM, Brown I, Carpenter RN, Mitchell JS. Uptake and therapeutic effectiveness of 1251- and 211At-methylene blue for pigmented melanoma in an animal model system. Cancer Res 1989; 49: 4332-4337.